VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
IRWD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
IRWDIronwood Pharmaceuticals, Inc.
$4.30$708M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksIRWDQuarterly Financials

Ironwood Pharmaceuticals, Inc. (IRWD) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Ironwood Pharmaceuticals, Inc. (IRWD) quarterly income statement — complete revenue, gross profit & net income history

IRWD Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue106.51M47.71M122.06M85.24M41.14M90.55M91.59M94.4M74.88M117.55M113.74M107.38M104.06M107.2M108.64M97.23M97.53M117.13M103.75M104.03M
Revenue Growth %158.87%-47.31%33.26%-9.7%-45.05%-22.98%-19.47%-12.09%-28.05%9.66%4.7%10.44%6.7%-8.48%4.71%-6.54%9.77%0.39%0.27%16.32%
Cost of Goods Sold443K0475K467K27.43M029.83M025.82M0507K19.78M286K340K363K360K10.82M358K10.91M12.16M
COGS % of Revenue0.42%-0.39%0.55%66.67%-32.57%-34.48%-0.45%18.42%0.27%0.32%0.33%0.37%11.1%0.31%10.51%11.69%
Gross Profit106.06M47.71M121.58M84.77M13.71M90.55M61.77M94.4M49.06M117.55M113.23M87.61M103.78M106.86M108.27M96.87M86.71M116.77M92.84M91.87M
Gross Margin %99.58%100%99.61%99.45%33.33%100%67.43%100%65.52%100%99.55%81.58%99.73%99.68%99.67%99.63%88.9%99.69%89.49%88.31%
Gross Profit Growth %673.56%-47.31%96.85%-10.2%-72.05%-22.98%-45.45%7.75%-52.72%10.01%4.58%-9.57%19.68%-8.49%16.62%5.45%18.19%0.85%13.53%3.46%
Operating Expenses33.53M41.16M43.9M39.7M42.82M59.05M36.13M69.42M38.04M79.96M64.62M1.17B43.68M38.5M39.8M41.22M28.86M60.18M27.67M26.77M
OpEx % of Revenue31.48%86.26%35.97%46.58%104.07%65.22%39.45%73.54%50.81%68.02%56.82%1090.26%41.97%35.91%36.64%42.39%29.59%51.38%26.67%25.73%
Selling, General & Admin12.03M19.29M21.91M16.8M033.59M36.11M36.96M038.67M32.35M31.58M31.12M28.39M28.62M30.12M28.86M28.69M00
SG&A % of Revenue11.3%40.44%17.95%19.7%-37.1%39.43%39.16%-32.89%28.44%29.41%29.9%26.48%26.34%30.98%29.59%24.49%--
Research & Development21.5M21.86M21.99M22.91M27.43M25.39M29.83M30.39M25.82M35.68M32.28M1.13B12.56M10.11M11.18M11.09M10.82M31.49M10.91M12.16M
R&D % of Revenue20.18%45.83%18.02%26.87%66.67%28.04%32.57%32.19%34.48%30.35%28.38%1047.69%12.07%9.43%10.29%11.41%11.1%26.89%10.51%11.69%
Other Operating Expenses00001000K73K-1000K1000K1000K1000K01000K0000-1000K01000K1000K
Operating Income72.53M6.55M77.68M45.07M-29.11M31.49M25.64M24.98M11.02M37.59M48.61M-1.08B60.1M68.36M68.47M55.66M57.85M56.59M65.17M65.1M
Operating Margin %68.1%13.74%63.64%52.88%-70.75%34.78%27.99%26.46%14.72%31.98%42.74%-1008.68%57.75%63.77%63.03%57.24%59.31%48.32%62.82%62.58%
Operating Income Growth %349.19%-79.19%203.03%80.45%-364.14%-16.22%-47.26%102.31%-81.66%-45.02%-29.01%-2046.17%3.89%20.8%5.07%-14.51%27.42%10.14%42.87%99%
EBITDA72.98M7.01M78.16M45.54M-28.63M31.98M26.14M25.48M11.53M38.13M49.12M-1.08B60.38M68.7M68.84M56.02M58.2M56.95M65.53M65.49M
EBITDA Margin %68.52%14.7%64.03%53.42%-69.58%35.32%28.54%27%15.4%32.43%43.18%-1008.43%58.03%64.09%63.36%57.61%59.68%48.62%63.16%62.96%
EBITDA Growth %354.9%-78.07%198.97%78.7%-348.24%-16.13%-46.77%102.35%-80.9%-44.51%-28.65%-2033.18%3.75%20.64%5.05%-14.47%27.05%9.93%38.14%96.37%
D&A (Non-Cash Add-back)443K460K475K467K479K485K507K506K513K537K507K270K286K340K363K360K355K358K358K396K
EBIT72.53M8.34M77.68M45.07M-10.55M32.91M26.79M26.35M11.46M39.99M41.77M56.02M67.39M73.79M71.43M55.99M57.85M54.21M65.1M64.82M
Net Interest Income-7.44M-6.43M-7.5M-7.54M-7.2M-8.14M-8.27M-6.1M-6.06M-7.23M-8.09M6.92M5.75M3.92M1.28M-1.19M-2.11M-7.77M-7.66M-7.56M
Interest Income1.7M1.46M930K818K869K778K1.15M1.37M1.17M1.19M1.75M8.76M7.27M5.45M2.81M1.02M230K180K178K172K
Interest Expense9.14M7.89M8.43M8.36M8.07M8.91M9.42M7.47M7.23M8.42M9.84M1.84M1.53M1.53M1.52M2.21M2.34M7.95M7.84M7.73M
Other Income/Expense-7.36M-6.1M-9.66M-7.25M-7.16M-7.5M-8.27M-6.1M-6.06M-7.23M-16.68M6.92M5.76M3.9M1.43M-1.87M-1.38M-10.34M-5.5M-10.73M
Pretax Income65.17M455K68.02M37.82M-36.27M24M17.37M18.88M4.96M30.36M31.93M-1.08B65.86M72.27M69.91M53.78M56.47M46.26M59.67M54.37M
Pretax Margin %61.19%0.95%55.73%44.37%-88.16%26.5%18.96%20%6.62%25.83%28.07%-1002.24%63.29%67.41%64.35%55.32%57.9%39.49%57.52%52.27%
Income Tax24.4M2.73M27.94M14.22M1.11M21.74M13.72M19.74M9.12M32.1M17.98M13.26M20.15M23.4M19.59M16.7M17.66M4.88M3.83M-336.93M
Effective Tax Rate %37.44%600.22%41.08%37.61%-3.07%90.6%79.01%104.56%183.95%105.75%56.31%-1.23%30.59%32.38%28.02%31.06%31.28%10.55%6.41%-619.68%
Net Income40.77M-2.28M40.08M23.6M-37.39M2.26M3.65M-860K-4.16M-1.09M15.32M-1.06B45.71M48.87M50.32M37.08M38.8M41.37M55.84M391.3M
Net Margin %38.28%-4.77%32.84%27.69%-90.87%2.49%3.98%-0.91%-5.56%-0.92%13.47%-989.17%43.93%45.59%46.32%38.14%39.78%35.32%53.83%376.14%
Net Income Growth %209.06%-200.89%999.29%2844.07%-798.27%307.54%-76.2%99.92%-109.1%-102.22%-69.55%-2964.58%17.82%18.11%-9.9%-90.52%-2.82%-4.24%62.23%1452.54%
Net Income (Continuing)40.77M-2.28M40.08M23.6M-37.39M2.26M3.65M-860K-4.16M-1.75M13.95M-1.09B45.71M48.87M50.32M37.08M38.8M41.37M55.84M391.3M
Discontinued Operations00000000000000000000
Minority Interest0000000000-2.46M-1.07M00000000
EPS (Diluted)0.24-0.010.230.14-0.230.010.02-0.01-0.03-0.010.08-6.840.250.260.270.210.200.250.342.39
EPS Growth %204.35%-190.78%908.77%--771.21%241%-72.2%99.92%-110.56%-103.85%-69.63%-3357.14%25%4%-20.59%-91.21%-20%-7.41%61.9%1393.75%
EPS (Basic)0.25-0.010.250.15-0.230.010.02-0.01-0.03-0.010.10-6.840.300.320.280.240.210.250.342.42
Diluted Shares Outstanding166.69M177.76M177.76M161.72M160.97M160.42M160.23M159.01M157.7M156.01M186.89M155.37M186.68M185.19M184.47M184.88M189.54M165.63M165.24M163.5M
Basic Shares Outstanding163.45M162.22M162.22M161.72M160.97M159.9M159.71M159.01M157.7M156.01M155.89M155.37M154.45M153.34M180.48M153.3M184.27M163.29M162.74M161.95M
Dividend Payout Ratio--------------------